Is oral BPC-157 as effective as injectable?

Injectable BPC-157 offers higher bioavailability by bypassing digestive degradation, with studies showing plasma detection within 15-30 minutes of administration. Oral BPC-157 demonstrates approximately 30-50% bioavailability in animal models, which is unusually high for a peptide since most are destroyed in the digestive tract. Research suggests oral forms may be more effective for gastrointestinal conditions, while injectable administration is preferred for musculoskeletal injuries requiring systemic tissue exposure.